Charles Comins
Impact in
-
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
-
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 3
- Oncology 8
- Lung Cancer Research Studies 4
- Co-authors
- Alan A. Melcher (3 shared papers)Kevin Joseph Harrington (3 shared papers)Hardev Pandha (3 shared papers)Victoria Roulstone (2 shared papers)James F. Spicer (1 shared paper)Mitch A. Phelps (1 shared paper)Katie R. Twigger (1 shared paper)Karl L. Mettinger (1 shared paper)
- Journals
- Clinical Oncology (3 papers)BMJ Open (2 papers)Journal of Clinical Oncology (2 papers)Lung Cancer (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- United KingdomSwitzerlandItaly
In The Last Decade
Charles Comins
24 papers receiving 518 citations
Charles Comins's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 191
- Pulmonary and Respiratory Medicine 162
- Biotechnology 47
- Genetics 149
- Infectious Diseases 57
Countries citing papers authored by Charles Comins
This map shows the geographic impact of Charles Comins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Comins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Comins more than expected).
Fields of papers citing papers by Charles Comins
This network shows the impact of papers produced by Charles Comins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Comins. The network helps show where Charles Comins may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Comins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 120 | |
| 2 | 2016 | 107 | |
| 3 | Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01 Hit paper breakdown → | 2024 | 106 |
| 4 | 2008 | 44 | |
| 5 | 2022 | 25 | |
| 6 | 2022 | 25 | |
| 7 | 2016 | 24 | |
| 8 | 2023 | 11 | |
| 9 | 2018 | 10 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2024 | 6 | |
| 14 | 2014 | 6 | |
| 15 | 2018 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2007 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2024 | 3 |
About Charles Comins
Charles Comins is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Radiation, having authored 26 papers that have together received 532 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (4 papers), Virus-based gene therapy research (3 papers), Breast Implant and Reconstruction (3 papers), Breast Cancer Treatment Studies (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers) and Advanced Radiotherapy Techniques (2 papers). The work is most often cited by research in Oncology (191 citations), Pulmonary and Respiratory Medicine (162 citations), Biotechnology (47 citations), Genetics (149 citations) and Infectious Diseases (57 citations). Charles Comins has collaborated with scholars based in United Kingdom, Switzerland and Italy. Frequent co-authors include Alan A. Melcher, Kevin Joseph Harrington, Hardev Pandha, Victoria Roulstone, James F. Spicer, Mitch A. Phelps, Katie R. Twigger, Karl L. Mettinger, Gerard James Nuovo and Matt C. Coffey. Their work appears in journals such as Clinical Oncology, BMJ Open, Journal of Clinical Oncology, Lung Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.